Standardy analityczne
- Cayman | 1 mg | 10004174-1 | 4-oxo-2-Nonenal-d3
- Cayman | 100 µg | 10004174-100 | 4-oxo-2-Nonenal-d3
- Cayman | 50 µg | 10004174-50 | 4-oxo-2-Nonenal-d3
- Cayman | 500 µg | 10004174-500 | 4-oxo-2-Nonenal-d3
- Cayman | 100 µg | 10004197-100 | Prostaglandin E2-1-glyceryl ester-d5
- Cayman | 50 µg | 10004197-50 | Prostaglandin E2-1-glyceryl ester-d5
- Cayman | 500 µg | 10004197-500 | Prostaglandin E2-1-glyceryl ester-d5
- Cayman | 1 mg | 10005056-1 | Eicosapentaenoic Acid-d5
- Cayman | 100 µg | 10005056-100 | Eicosapentaenoic Acid-d5
- Cayman | 50 µg | 10005056-50 | Eicosapentaenoic Acid-d5
- Cayman | 500 µg | 10005056-500 | Eicosapentaenoic Acid-d5
- Cayman | 1 mg | 10005057-1 | Docosahexaenoic Acid-d5
- Cayman | 100 µg | 10005057-100 | Docosahexaenoic Acid-d5
- Cayman | 50 µg | 10005057-50 | Docosahexaenoic Acid-d5
- Cayman | 500 µg | 10005057-500 | Docosahexaenoic Acid-d5
- Cayman | 100 mg | 10005426-100 | Orlistat
- Cayman | 250 mg | 10005426-250 | Orlistat
- Cayman | 50 mg | 10005426-50 | Orlistat
- Cayman | 500 mg | 10005426-500 | Orlistat
- Cayman | 100 µg | 10005615-100 | PtdIns-(4,5)-P2 (1,2-dipalmitoyl)-d62 (sodium salt)
- Cayman | 25 µg | 10005615-25 | PtdIns-(4,5)-P2 (1,2-dipalmitoyl)-d62 (sodium salt)
- Cayman | 50 µg | 10005615-50 | PtdIns-(4,5)-P2 (1,2-dipalmitoyl)-d62 (sodium salt)
- Cayman | 100 µg | 10005616-100 | PtdIns-(3)-P1 (1,2-dipalmitoyl)-d62 (ammonium salt)
- Cayman | 25 µg | 10005616-25 | PtdIns-(3)-P1 (1,2-dipalmitoyl)-d62 (ammonium salt)
- Cayman | 50 µg | 10005616-50 | PtdIns-(3)-P1 (1,2-dipalmitoyl)-d62 (ammonium salt)
- Cayman | 100 µg | 10006197-100 | Leukotriene A4-d5 methyl ester
- Cayman | 25 µg | 10006197-25 | Leukotriene A4-d5 methyl ester
- Cayman | 50 µg | 10006197-50 | Leukotriene A4-d5 methyl ester
- Cayman | 100 µg | 10006198-100 | Leukotriene C4-d5
- Cayman | 25 µg | 10006198-25 | Leukotriene C4-d5
- Cayman | 50 µg | 10006198-50 | Leukotriene C4-d5
- Cayman | 100 µg | 10006199-100 | Leukotriene D4-d5
- Cayman | 25 µg | 10006199-25 | Leukotriene D4-d5
- Cayman | 50 µg | 10006199-50 | Leukotriene D4-d5
- Cayman | 100 µg | 10006410-100 | (±)14(15)-EET-d11
- Cayman | 25 µg | 10006410-25 | (±)14(15)-EET-d11
- Cayman | 50 µg | 10006410-50 | (±)14(15)-EET-d11
- Cayman | 10 µg | 10006413-10 | (±)11(12)-EET-d11
- Cayman | 100 µg | 10006413-100 | (±)11(12)-EET-d11
- Cayman | 25 µg | 10006413-25 | (±)11(12)-EET-d11
- Cayman | 50 µg | 10006413-50 | (±)11(12)-EET-d11
- Cayman | 1 mg | 10006556-1 | Latanoprost-d4
- Cayman | 100 µg | 10006556-100 | Latanoprost-d4
- Cayman | 50 µg | 10006556-50 | Latanoprost-d4
- Cayman | 500 µg | 10006556-500 | Latanoprost-d4
- Cayman | 10 µg | 10006654-10 | (±)5-iPF2α-VI-d11
- Cayman | 25 µg | 10006654-25 | (±)5-iPF2α-VI-d11
- Cayman | 1 mg | 10006758-1 | Arachidonic Acid-d11
- Cayman | 100 µg | 10006758-100 | Arachidonic Acid-d11
- Cayman | 250 µg | 10006758-250 | Arachidonic Acid-d11